Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page
- Check3 days agoChange DetectedThe page now includes new guidance and join sections (How to Read a Study Record, Common Questions, How to Join a Study) and indicates that recruitment is closed ('No longer looking for participants'). Additionally, the 'Intervention / Treatment' heading was removed and the older revision note ('Revision: v3.5.5') was dropped, reflecting an updated and streamlined study page.SummaryDifference0.4%

- Check10 days agoChange DetectedFooter revision tag updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new site build version.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.4 has been added, replacing the previous v3.5.3. This appears to be a minor update to the site framework or page rendering rather than a substantive change to the study details.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision has been updated to v3.5.3, indicating a new build of the ClinicalTrials.gov page. No changes to the study details or eligibility information are evident.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision banner updated to v3.5.2; the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.